tiprankstipranks
Voyager Therapeutics (MX:VYGR)
:VYGR
Mexico Market
VYGR
Voyager Therapeutics
RESEARCH TOOLSreports

Voyager Therapeutics (VYGR) Income Statement

0 Followers

Voyager Therapeutics Income Statement

Last quarter (Q2 2026), Voyager Therapeutics's total revenue was $3.17M, a decrease of -39.13% from the same quarter last year. In Q2, Voyager Therapeutics's net income was $-24.47M. See Voyager Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 40.37M$ 80.00M$ 250.01M$ 40.91M$ 37.41M
Gross Profit
$ -91.90M$ 80.00M$ 157.84M$ -14.86M$ -36.37M
Operating Expenses
$ 39.94M$ 163.29M$ 35.82M$ 35.98M$ 37.25M
Depreciation and Amortization
$ 4.06M$ 4.73M$ 4.44M$ 6.19M$ 5.17M
EBITDA
$ -115.52M$ -59.61M$ 138.18M$ -39.65M$ -66.03M
Operating Income
$ -131.84M$ -83.29M$ 122.01M$ -50.84M$ -73.62M
Other Income/Expenses
$ 12.27M$ 18.95M$ 11.72M$ 4.45M$ 2.42M
Pretax Income
$ -119.58M$ -64.34M$ 133.74M$ -46.39M$ -71.20M
Net Income
$ -119.72M$ -65.00M$ 132.33M$ -46.41M$ -71.20M
Per Share Metrics
Basic EPS
$ -2.04$ -1.13$ 3.08$ -1.21$ -1.75
Diluted EPS
$ -2.04$ -1.13$ 2.97$ -1.21$ -1.75
Weighted Average Shares Outstanding
 58.69M 57.67M 43.02M 38.36M 37.67M
Weighted Average Shares Outstanding (Diluted)
 58.69M 57.67M 44.57M 38.36M 37.67M
Currency in USD

Voyager Therapeutics Earnings and Revenue History